Employees work in a granulation unit at pharmaceutical firm Laurus Labs in Visakhapatnam, India, as the country looks to reduce its dependence on Chinese drug ingredients. Photo: Bloomberg
Employees work in a granulation unit at pharmaceutical firm Laurus Labs in Visakhapatnam, India, as the country looks to reduce its dependence on Chinese drug ingredients. Photo: Bloomberg
China trade

India needs China for critical medicine ingredients, but an ambitious initiative aims to correct that

  • Relying on China for active pharmaceutical ingredients has proved troublesome for Indian drug makers during the pandemic, but it’s a problem decades in the making
  • New data shows dozens of funding applications have been approved in India to bolster production of crucial drug components – many of which come mainly from China

Employees work in a granulation unit at pharmaceutical firm Laurus Labs in Visakhapatnam, India, as the country looks to reduce its dependence on Chinese drug ingredients. Photo: Bloomberg
Employees work in a granulation unit at pharmaceutical firm Laurus Labs in Visakhapatnam, India, as the country looks to reduce its dependence on Chinese drug ingredients. Photo: Bloomberg
READ FULL ARTICLE